Breast Cancer Treatment in India: Success Rates, Costs & Top Hospitals 2025

Comprehensive guide to breast cancer care in India — stage-wise survival rates, treatment options (surgery, chemo, radiation, targeted therapy, hormone therapy), and average costs at top Indian hospitals.

Breast Cancer in India: Key Statistics

Breast cancer is the most common cancer among women in India, accounting for 14% of all female cancers. India's top hospitals report 5-year survival rates of 85–90% for Stage I, 70–80% for Stage II, and 55–65% for Stage III breast cancer — comparable to US benchmarks.

Treatment Options Available in India

• Breast-conserving surgery (lumpectomy) and modified radical mastectomy
• Oncoplastic breast surgery with reconstruction
• Neoadjuvant and adjuvant chemotherapy
• Targeted therapy: Trastuzumab (Herceptin) for HER2+ cancers
• Hormonal therapy: Tamoxifen, Letrozole, Fulvestrant
• Radiation therapy: IMRT, IGRT, brachytherapy
• Immunotherapy: Pembrolizumab for triple-negative breast cancer

Cost of Breast Cancer Treatment in India

• Modified radical mastectomy: ₹2.5–5 lakh ($3,000–6,000)
• Chemotherapy (6 cycles): ₹2–6 lakh ($2,500–7,500)
• Trastuzumab (Herceptin) course: ₹8–15 lakh ($10,000–18,000)
• Radiation therapy (20 sessions): ₹1.5–3 lakh ($1,800–3,600)
• Total comprehensive treatment: ₹8–25 lakh ($10,000–30,000) — vs $80,000–200,000 in USA